Literature DB >> 18239738

Cardiovascular risk in women after metabolic complications in pregnancy.

A H E M Maas1, A W J van 't Hof, M J de Boer.   

Abstract

Hypertensive pregnancy disorders complicate 10% of all pregnancies. In this article we discuss the spectrum of hypertensive conditions that may occur during pregnancy. Recent studies have consistently shown that hypertensive disorders in pregnancy implicate a two-fold higher risk for the development of hypertension and cardiovascular disease later in life. To optimise preventive management of cardiovascular disease in women with previous complicated pregnancies, we therefore recommend monitoring of hypertension and other cardiac risk factors at an early stage in life. Furthermore, the obstetric history should be routinely incorporated in cardiovascular risk assessment in women who seek medical attention for hypertension and/or cardiac symptoms. (Neth Heart J 2007;15:415-7.).

Entities:  

Keywords:  hypertension; pregnancy; risk assessment; women

Year:  2007        PMID: 18239738      PMCID: PMC2213446          DOI: 10.1007/BF03086042

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  29 in total

Review 1.  Gestational diabetes mellitus.

Authors:  S L Kjos; T A Buchanan
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

Review 2.  Subclassification of preeclampsia.

Authors:  Peter von Dadelszen; Laura A Magee; James M Roberts
Journal:  Hypertens Pregnancy       Date:  2003       Impact factor: 2.108

3.  Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.

Authors:  Patricia K Agatisa; Roberta B Ness; James M Roberts; Joseph P Costantino; Lewis H Kuller; Margaret K McLaughlin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04       Impact factor: 4.733

4.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study.

Authors:  Brenda J Wilson; M Stuart Watson; Gordon J Prescott; Sarah Sunderland; Doris M Campbell; Philip Hannaford; W Cairns S Smith
Journal:  BMJ       Date:  2003-04-19

5.  The interval between pregnancies and the risk of preeclampsia.

Authors:  Rolv Skjaerven; Allen J Wilcox; Rolv T Lie
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

6.  High blood pressure in pregnancy and coronary calcification.

Authors:  Siamak Sabour; Arie Franx; Annemarieke Rutten; Diederick E Grobbee; Mathias Prokop; Marie-Louise Bartelink; Yvonne T van der Schouw; Michiel L Bots
Journal:  Hypertension       Date:  2007-02-05       Impact factor: 10.190

7.  Gender-based differences in the prognostic value of coronary calcification.

Authors:  Paolo Raggi; Leslee J Shaw; Daniel S Berman; Tracy Q Callister
Journal:  J Womens Health (Larchmt)       Date:  2004-04       Impact factor: 2.681

8.  Cardiovascular risk in women after metabolic complications in pregnancy.

Authors:  A H E M Maas; A W J van 't Hof; M J de Boer
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

9.  Classic and novel risk factor parameters in women with a history of preeclampsia.

Authors:  Naveed Sattar; Jane Ramsay; Lynne Crawford; Helen Cheyne; Ian A Greer
Journal:  Hypertension       Date:  2003-05-12       Impact factor: 10.190

10.  Hypertensive pregnancy disorders: current concepts.

Authors:  Steven J Wagner; Snezana Barac; Vesna D Garovic
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-07       Impact factor: 3.738

View more
  3 in total

1.  Cardiovascular risk in women after metabolic complications in pregnancy.

Authors:  A H E M Maas; A W J van 't Hof; M J de Boer
Journal:  Neth Heart J       Date:  2007-12       Impact factor: 2.380

2.  [Not Available].

Authors:  E E van der Wall
Journal:  Neth Heart J       Date:  2011-01       Impact factor: 2.380

3.  Gestational diabetes mellitus and obstetric outcomes in a Ghanaian community.

Authors:  Ahmed Tijani Bawah; Robert Amadu Ngala; Huseini Alidu; Mohammed Mustapha Seini; Joshua Dokurugu Kwame Wumbee; Francis Agyemang Yeboah
Journal:  Pan Afr Med J       Date:  2019-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.